4.7 Article

Amphetamine Trials and Tribulations

Journal

STROKE
Volume 40, Issue 3, Pages S133-S135

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.108.533703

Keywords

amphetamine; stroke; recovery; humans

Funding

  1. Department of Veterans Affairs
  2. NIH [NS 39934]

Ask authors/readers for more resources

Background-Laboratory experiments conducted since the 1940s show that amphetamine combined with task-relevant experience improves postbrain injury behavioral outcomes. Several small clinical trials evaluated the approach as a means of improving poststroke recovery. Results of Review-In laboratory studies, the effect of amphetamine on recovery depends on the location and extent of brain injury, the dosing and timing of amphetamine, and the type, intensity, and timing of concomitant behavioral training. The small clinical trials conducted to date vary considerably in critical aspects of their designs and are largely negative. Conclusion-The question of whether d-amphetamine combined with physiotherapy is of any clinical value remains unanswered. (Stroke. 2009; 40[suppl 1]: S133-S135.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Medicine, General & Internal

Screening for Asymptomatic Carotid Artery Stenosis Lack of Clinical Benefit, Potential for Harm

Larry B. Goldstein

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Clinical Neurology

Treatments-Preventive

Else Charlotte Sandset, Larry B. Goldstein

STROKE (2021)

Review Clinical Neurology

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

Narayanaswamy Venketasubramanian, Craig Anderson, Hakan Ay, Selma Aybek, Waleed Brinjikji, Gabriel R. de Freitas, Oscar H. Del Brutto, Klaus Fassbender, Miki Fujimura, Larry B. Goldstein, Roman L. Haberl, Graeme J. Hankey, Wolf-Dieter Heiss, Isabel Lestro Henriques, Carlos S. Kase, Jong S. Kim, Masatoshi Koga, Yoshihiro Kokubo, Satoshi Kuroda, Kiwon Lee, Tsong-Hai Lee, David S. Liebeskind, Gregory Y. H. Lip, Stephen Meairs, Roman Medvedev, Man Mohan Mehndiratta, Jay P. Mohr, Masao Nagayama, Leonardo Pantoni, Panagiotis Papanagiotou, Guillermo Parrilla, Daniele Pastori, Sarah T. Pendlebury, Luther Creed Pettigrew, Pushpendra N. Renjen, Tatjana Rundek, Ulf Schminke, Yukito Shinohara, Wai Kwong Tang, Kazunori Toyoda, Katja E. Wartenberg, Mohammad Wasay, Michael G. Hennerici

Summary: The COVID-19 pandemic has posed challenges for stroke management, with clinicians facing various etiologies for stroke compounded by unique complications associated with the virus. Strict infection control measures and continuous medical care are essential throughout the patient care journey.

CEREBROVASCULAR DISEASES (2021)

Article Clinical Neurology

Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report

Greg A. Jicha, Erin L. Abner, Steven E. Arnold, Maria C. Carrillo, Hiroko H. Dodge, Steven D. Edland, Keith N. Fargo, Howard H. Feldman, Larry B. Goldstein, James Hendrix, Ruth Peters, Julie M. Robillard, Lon S. Schneider, Jodi R. Titiner, Christopher J. Weber

Summary: Consensus guidance has been developed for the development and conduct of high-quality Alzheimer's disease clinical trials, covering aspects such as scientific justification, trial registration, conflict of interest disclosure, and defined trial population. This guidance aims to assist in protocol development and may also support the education of potential trial participants and the public on appropriate clinical trial participation decisions.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

Advances in Stroke: Treatments-Preventive

Else Charlotte Sandset, Larry B. Goldstein

STROKE (2022)

Letter Clinical Neurology

Disparities in Internet Use Among US Stroke Survivors: Implications for Telerehabilitation During COVID-19 and Beyond

Zhu Cenjing, Phoebe M. Tran, Rachel P. Dreyer, Larry B. Goldstein, Judith H. Lichtman

STROKE (2022)

Article Neurosciences

Paradoxical Cerebral Air Embolism after Cardiac Ablation in Williams-Beuren Syndrome: A Clinico-Pathological Correlation

Dana L. Ionel, Fred O. Odago, Andre N. Ene, Jessica D. Lee, William N. O'Connor, Larry B. Goldstein, L. Creed Pettigrew

Summary: In this case report, we describe a patient with Williams-Beuren syndrome who experienced sudden neurological deterioration following a cardiac ablative procedure. Williams-Beuren syndrome is a rare genetic disorder with distinctive clinical features. Chromosomal microdeletion leads to various neurological and cardiac complications.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2022)

Article Clinical Neurology

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory

Tanya N. Turan, Osama O. Zaidat, Gary S. Gronseth, Marc Chimowitz, Antonio Culebras, Anthony J. Furlan, Larry B. Goldstein, Nestor R. Gonzalez, Julius G. Latorre, Steven R. Messe, Thanh N. Nguyen, Rajbeer S. Sangha, Michael J. Schneck, Aneesh B. Singhal, Lawrence R. Wechsler, Alejandro A. Rabinstein, Mary Dolan O'Brien, Heather Silsbee, Jeffrey J. Fletcher

Summary: This study reviewed treatments for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS). The major recommendations include prescribing aspirin and clopidogrel for long-term prevention of stroke, recommending high-intensity statin therapy, maintaining target blood pressure levels, engaging in regular physical activity, and treating other modifiable vascular risk factors. The study also advises against certain procedures such as angioplasty and stenting for stroke prevention in moderate or severe sICAS patients.

NEUROLOGY (2022)

Article Clinical Neurology

Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage A Danish Nationwide Case-Control Study

Daniel Albjerg Rudolph, Stine Munk Hald, Luis Alberto Garcia Rodriguez, Soren Moller, Jesper Hallas, Larry B. Goldstein, David Gaist

Summary: The study demonstrates an association between long-term statin use and a lower risk of intracerebral hemorrhage.

NEUROLOGY (2022)

Article Cardiac & Cardiovascular Systems

Rural Residence and Antihypertensive Medication Use in US Stroke Survivors

Phoebe M. Tran, Lam T. Tran, Cenjing Zhu, Tiffany Chang, Inna P. Powers, Larry B. Goldstein, Judith H. Lichtman

Summary: Poststroke antihypertensive use is comparable in rural and urban stroke survivors with a reported history of hypertension, but there is a trend for increased use among urban residents.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Clinical Neurology

Trends in 1-Year Recurrent Ischemic Stroke in the US Medicare Fee-for-Service Population

Erica C. Leifheit, Yun Wang, Larry B. Goldstein, Judith H. Lichtman

Summary: Data on trends in recurrent stroke in the US are limited, but this study found an overall decrease in recurrent ischemic strokes from 2001 to 2017. However, there were geographic areas with persistently higher recurrence rates.

STROKE (2022)

Article Clinical Neurology

Associations Between Long-Term Air Pollutant Exposure and 30-Day All-Cause Hospital Readmissions in US Patients With Stroke

Phoebe M. M. Tran, Joshua L. L. Warren, Erica C. C. Leifheit, Larry B. B. Goldstein, Judith H. H. Lichtman

Summary: Long-term exposure to air pollutants is associated with increased risk of hospital readmission within 30 days after stroke, regardless of hospital performance category. The study assessed the relationship between exposure to carbon monoxide, nitrogen dioxide, ozone, particulate matter 2.5, and sulfur dioxide and 30-day all-cause hospital readmission in elderly stroke patients. Despite being below national limits, long-term exposure to air pollutants still increased the risk of readmission.

STROKE (2023)

Article Biochemistry & Molecular Biology

Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood

Deepak Kotiya, Noah Leibold, Nirmal Verma, Gregory A. Jicha, Larry B. Goldstein, Florin Despa

Summary: Amylin-A beta co-aggregation plays a significant role in Alzheimer's disease (AD), but its mechanisms are not fully understood. In this study, a new ELISA method was developed to detect amylin-A beta hetero-oligomers in brain tissue and blood. The results showed that this assay is sensitive to circulating amylin-A beta hetero-oligomers in the blood and may contribute to understanding and treating the development of AD.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Editorial Material Clinical Neurology

Advances in Stroke: Treatments-Preventive

Else Charlotte Sandset, Larry B. Goldstein

STROKE (2023)

No Data Available